INTRODUCTION
The human immunodeficiency virus (HIV-1) encodes a transcriptional activator protein, Tat, which increases the processivity of RNA polymerase II (for reviews, see ref. (1) (2) (3) ). Tat activates transcription through binding to the upper stem and bulge region of TAR, a structured element in the nascent viral RNA, and controls a DRB-sensitive step early in RNAPII transcription elongation that results in hyperphosphorylation of the carboxy-terminal domain (CTD) of RNA polymerase II. In nuclear extracts, HIV-1 Tat associates tightly with the CDK9-containing positive transcription elongation factor complex, P-TEFb (4) (5) (6) . Recent studies indicate that Tat binds directly through its trans-activation domain to the cyclin subunit (CycT1) of the P-TEFb complex and induces loop sequence-specific binding of the P-TEFb complex to TAR RNA (7) (8) (9) . Neither CycT1 nor the P-TEFb complex bind TAR RNA in the absence of Tat, and thus the binding is highly co-operative for both Tat and P-TEFb (7, 9) . The Tat:CycT1 interaction requires zinc as well as cysteine residues in each protein, and therefore may represent a metal-linked heterodimer (8) . Tat appears to contact residues in the carboxy-terminal boundary of the CycT1 cyclin domain which are not critical for binding of cyclinT1 to CDK9 (8, (10) (11) (12) (13) (14) , and basic residues in CycT1 (R251, R254) further stabilize the Tat:P-TEFb: TAR RNA complex (8) . Thus the assembly of this complex appears to involve a series of adaptive interactions between the trans-activation and arginine-rich motif (RNA-binding) domains of Tat and their respective protein (CycT1) and nucleic acid (TAR) partners during transcription.
These studies have raised the possibility that at least two separate events may govern the assembly of functional P-TEFb:Tat:TAR complexes: 1) the interaction of Tat with CycT1 induces a conformational change in Tat that enhances its affinity and kinetic stability for TAR RNA, and 2) TAR RNA may enhance the affinity between CycT1 and Tat, through an "induced fit" mechanism.
These two events would not necessarily be mutually exclusive, and both could contribute by guest on January 21, 2018 http://www.jbc.org/ Downloaded from 4 significantly to the assembly of a stable ternary complex necessary to position P-TEFb at the RNA exit channel in a location favorable for phosphorylation of the RNAPII CTD. To test these hypotheses, we developed a fluorescence resonance energy transfer (FRET) system containing TAR RNA and Tat protein uniquely labeled with donor and acceptor dye molecules (Figure 1) .
FRET, in which a fluorescent donor molecule transfers energy via a non-radiative dipole-dipole interaction to an acceptor molecule (which is usually also a fluorescent molecule) is a standard spectroscopic technique for measuring distances in the 10-70 Å range (15, 16) . The donor's lifetime and quantum yield are reduced upon energy transfer, and the acceptor fluorescence is increased, or sensitized. Quantification of the efficiency of energy transfer allows determination of the distance between the two fluorophores. We used a well-characterized donor-acceptor dyepair, fluorescein-rhodamine, for FRET experiments. Our results demonstrate that CycT1 enhances the affinity and kinetic stability of Tat-TAR complex formation. In addition, it was discovered that TAR RNA enhances CycT1 and Tat interaction showing how a small RNA hairpin can provide a platform for protein-protein interactions.
EXPERIMENTAL PROCEDURES

RNA Synthesis
RNAs were synthesized by chemical and enzymatic methods. Modified TAR RNA was synthesized on an Applied Biosystems Model 392 DNA/RNA synthesizer using 2-cyanoethyl phosphoramidite chemistry. All the monomers of (2-cyanoethyl)phosphoramidites were obtained from Glen Research (Sterling, Virginia). TAR RNA was chemically synthesized on a fluoresceincontaining CPG 500 support. RNA (1 µmole) containing fluorescein was deprotected by treatment with NH 3 saturated methanol (2 mL) at 25 o C for 17 h. Product was filtered and dried in Speedvac.
To deprotect 2'-OH silyl groups, the red pellet was dissolved in 50% triethylamine trihydrofluoride in dimethyl sulfoxide (0.5 mL) and left at room temperature for 16 h. Deprotected 5 RNA was precipitated by the addition of 2 mL of isopropyl alcohol. After deprotection, RNA was purified and characterized as described previously (17) (18) (19) .
Wild-type and mutant TAR RNAs were prepared by in vitro transcription (20, 21) . This enzyme yields U and C specific cleavage of RNA. Sequencing products were resolved on 20 % denaturing gels and visualized by phosphor image analysis.
Tat and CyclinT1 Proteins
Tat protein (aa1-72) was chemically synthesized using standard F-moc amino acids and 5-carboxytetramethylrhodamine was incorporated at K19 position. Details of Tat-Rhodamine synthesis will be described elsewhere (Tamilarasu and Rana, unpublished data). Rhodaminelabeled Tat (aa1-72) was purified by HPLC and characterized by mass spectrometry. In vitro transcription assays and electrophoretic mobility shift experiments showed that the rhodamine labeling did not significantly alter the structure of Tat which can interfere with its function (data not shown).
Human CycT1 (aa 1-303 and aa 1-254) was expressed as GST-fusion protein, purified, and characterized as described previously (7, 8) .
Fluorescence Resonance Energy Transfer Measurements (FRET)
The fluorescence measurements were performed on PTI fluorescence spectrophotometer controlled by Felix software. The excitation wavelength was 490 nm and slits width was set 3. What is the affinity of CycT1-Tat interactions and does TAR RNA play any role in this interaction? To address this question, we measured rhodamine fluorescence quenching at 575 nm by titration of CycT1 (aa1-303) with Tat-Rh. Figure 3A shows the best fit of the data using (29)). The regulation of protein interaction through structural alterations in the RNA could be an important mechanism for controlling the order of assembly of the Tat:P-TEFb:TAR complex both to ensure that Tat will not commit to TAR in the absence of CycT1(P-TEFb) and, similarly, to 13 ensure that P-TEFb is preferentially utilized at the viral promoter, since cellular genes do not express TAR RNA. The ability to remodel a transcriptional activator through interaction with protein and nucleic acids partners could also be important for exchanging Tat protein with other possible partners. Thus, after phosphorylation of the RNAPII CTD, Tat has been shown to interact with RNA polymerase II rather than TAR (34) . The mechanism that controls the dissassembly of the stable Tat:P-TEFb:TAR complex is unknown, but may rely on the ability of the Tat protein to model itself to available surfaces on the RNA polymerase elongation complex. These findings with the Tat and lambda N proteins highlight the versatility of RNA as an enhancer of specific protein:protein interactions. 
